• In recent weeks, Waters Corporation reported Q1 results that topped Wall Street expectations for both earnings per share and revenue, while investors also learned that all director nominees were re-elected and PricewaterhouseCoopers LLP was ratified as the independent auditor for fiscal 2026 at the completed annual stockholder meeting.
• These developments have reinforced analysts’ cautiously optimistic view of Waters, with the earnings beat and confirmed governance framework seen as supportive of the company’s longer-term positioning in analytical workflow solutions.
• We’ll now examine how Waters’ stronger-than-expected Q1 performance and renewed analyst optimism may shape the company’s broader investment narrative.

Find 47 companies with promising cash flow potential yet trading below their fair value.

Waters Investment Narrative Recap

To own Waters, you need to believe in its role as a core provider of analytical workflow solutions while it manages integration, margin, and end‑market pressures. The recent Q1 beat against expectations supports the near term catalyst of renewed confidence in execution, but does not materially reduce the key risk around integrating BD’s Biosciences and Diagnostic Solutions businesses and delivering the sizeable cost and revenue synergies that many forecasts rely on.

The most relevant recent development here is Waters’ Q1 2026 earnings, where revenue reached US$1,267 million, ahead of guidance, but with a reported net loss driven by large one off items. That mix of stronger demand signals and compressed profitability sits right at the intersection of the integration and margin risks, and will likely shape how investors weigh the upside from BD’s assets against the execution challenges in the coming quarters.

Yet beneath the upbeat Q1 reaction, one risk investors should be aware of is how much now hinges on successful integration of BD’s businesses and...

Waters’ narrative projects $7.5 billion revenue and $1.4 billion earnings by 2029.

Uncover how Waters' forecasts yield a $393.14 fair value, a 15% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already assuming Waters could reach about US$8.3 billion in revenue and US$1.4 billion in earnings by 2029, so Q1’s surprise leaves open the question of whether that upbeat view or the more cautious concerns about overreliance on core technologies and digital gaps will end up closer to how things actually unfold.

Explore 3 other fair value estimates on Waters - why the stock might be worth just $393.14!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Waters research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Waters research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Waters' overall financial health at a glance.

Want Some Alternatives?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• Outshine the giants: these 13 early-stage AI stocks could fund your retirement.
• Capitalize on the AI infrastructure supercycle with our selection of the 47 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.